Important. These pages are retained here for historical purposes only and some of the information may be deprecated. The ICNA would like to thank everyone for making the congresses a great success. We look forward to welcoming you again in Mumbai, India in 2018

MONDAY MAY 05 2014
Abstracts selected for presentation will be available online by April 15, 2014
08:00-09:00 PL01 The revolution in epilepsy genetics changes clinical practice Ingrid Scheffer, Australia
09:00-10:00 PL02 What can we reasonably expect from stem cell therapy- beyond the hype and the hope? Alan Mackay-Sim, Australia
10:30-12:30 S01 Focal Epilepsies - Advances in Genetics 
  Chair: Ingrid Scheffer (Australia)
Familial focal epilepsy with variable foci – a common molecular focal epilepsy Ingrid Scheffer , Australia
How to approach molecular testing of focal epileptic encephalopathies  Heather Mefford, USA
Migrating focal seizures of infancy, a genetic epileptic encephalopathy Rima Nabbout, France
Autosomal dominant nocturnal frontal lobe epilepsy – not just a disorder of nicotinic receptors Shinichi Hirose, Japan
10:30-12:30 S02 Autoimmune Neuropsychiatric Disorders 
  Chair: Hilla Ben-Pazi, Israel
Should PANDAS/ CANS be considered separate entity? Hilla Ben-Pazi , Israel
Sydenham's chorea: What in new in this old disorder? Francisco E.C. Cardoso, Brazil
 Neuroinflammation in Opsoclonus-Myoclonus Syndrome: What's New? Michael R Pranzatelli, USA
Pathophysiologic role of anti-NMDA, anti-VGKC and anti-dopamine receptor autoantibodies Russell Dale, Australia
10:30-12:30 S03 Neurometabolic Disorders - Treatment Update 
  Chairs: Ingrid Tein (Canada) / Linda DeMeirleir (Canada)
Treatment update in fatty acid oxidation disorders Ingrid Tein, Canada
Treatment update in lysosomal storage disorders Linda DeMeirleir, Belgium
Treatment update in neuronal ceroid lipofuscinoses Rose-Mary Boustany, Lebanon
Treatment update in mitochondrial disorders  
10:30-12:30 S04 Brain Stimulation in Children - Neurophysiology and Therapeutics 
  Chair: Adam Kirton (Canada)
Measuring, Mapping, and Modulating Cortical Inhibition and Neuroplasticity in Tourette Syndrome and ADHD Donald Gilbert, USA
Translational brain stimulation: informing clinical protocols in children by basic research Alexander Rotenberg, USA
Enhancing developmental neuroplasticity after perinatal stroke with non-invasive brain stimulation Adam Kirton , Canada
DBS for Childhood Dystonias: Who to select and how to Measure Outcomes? Jean-Pierre Lin, UK
Chair: TBA
0200 - 0215 PM FP01 Glial Precursor Cell Transplantation Improves Behavioral and Neuropathological Outcome in a Model of Neonatal White Matter Injury Ali Fatemi, USA
0215 - 0230 PM FP02 Go for the Cause: Significant Genomic Rearrangements in Cryptogenic Cerebral Palsy Hilla Ben-pazi, Israel
0230 - 0245 PM FP03 Development of a portable electronic goniodynamometer for the evaluation of equinus foot in cerebral palsy. Eduardo Fusão, Brazil
0245 - 0300 PM FP04 Repetitive transcranial magnetic stimulation effects on motor learning in perinatal stroke: Short-term outcomes from the PLASTIC CHAMPS trial. Adam Kirton, Canada
0300 - 0315 PM FP05 Comparative Study of Baclofen and Tizanidine in Reducing Spasticity in Cerebral Palsy- A Randomized Controlled Trial Narayan Saha, Bangladesh
0315 - 0330 PM FP06 Cerebellar vermal involvement in patients with hypoxic-ischemic encephalopathy and relation to cognitive functions. Heba El Khashab, Egypt
0330 - 0345 PM FP07 Prevalence & Risk Factors for neurological disorders in children aged 9-15 years in northern India Rashmi Kumar, India
0345 - 0400 PM FP08 Neurological manifestations of Incontinentia Pigmenti Inmaculada Carreras Sáez, Spain
0400 - 0415 PM FP09 Hemiplegic Cerebral Palsy- Etiology , clinical features and outcome Eli Lahat, Israel
0415 - 0430 PM FP10 Psychiatric Disorder associated with Cerebral Palsy Alessandra Freitas Russo, Brazil
0430- 0445 PM FP11 The biomechanical methods of gait evaluation in children with cerebral palsy IIona Kopyta, Poland
0445 - 0500 PM FP12 Concerns and felt needs of parents of disabled children living in urban slums Samata Singhi, USA
Chair: TBA
0200 - 0215 PM FP21 De Novo DiGenic Heterozygous Mutations in EZR and NR2E3 revealed by Exome Sequencing in a patient with Cataract, Retinal Degeneration, Epilepsy and Leukodystrophy Majed Dasouki, Saudi Arabia
0215 - 0230 PM FP14 Identification of genes for autosomal recessive microcephaly by whole-exome sequencing Ganeshwaran Mochida, USA
0230 - 0245 PM FP15 Outcome of Hematopoietic Stem Cell Tranplant (HCT) in childhood cerebral Adrenoleukodystrophy (CCALD): a Multi-Institutional Study Asif Paker, USA
0245 - 0300 PM FP16 Patient-derived stem cells as models for familial brain disorders Alan Mackay-Sim, Australia
0300 - 0315 PM FP17 An approach to genotype-phenotype correlation in rett syndrome Paulina Carullo, Argentina
0315 - 0330 PM FP18 Episodic weakness, cerebellar ataxia, deafness and optic atrophy - a new phenotype of a novel ATP1A3 mutation Bruria Ben-Zeev, Israel
0330 - 0345 PM FP19 Molecular characterization in children with attention deficit and hyperactivity disorder Alberto Velez Van Meerbeke, Colombia
0345 - 0400 PM FP20 Novel MLC1 and GLIACAM mutations analysis and follow-up study in Chinese patients with Megalencephalic Leukoencephalotathy with Subcortical Cysts Jingmin Wang, China
0400 - 0415 PM FP13  Expanding the Genetic Landscape of Neurodevelopmental Disorders with Whole Exome Sequencing Ali Fatemi, USA
0415 - 0430 PM FP22 Follow up study of 34 Chinese patients with vanishing white matter disease and role of UPR and autophagy in the pathogenesis Ye Wu, China
0430 - 0445 PM FP23 Proteolipid protein 1 and gap junction α12 gene mutations in 72 Chinese patients with Pelizaeus-Merzbacher disease/ Pelizaeus-Merzbacher like disease and prenatal diagnosis of 15 fetuses in twelve Chinese families with PMD probands Jingmin Wang, China
0445 - 0500 PM FP24 The 9p13 Deletion Syndrome: Confirmation and Expansion of the Phenotype Majed Dasouki, Saudi Arabia
Chair: TBA
0200 - 0215 PM FP37 Bone Health Screening Practices Amongst Boston Children's Hospital Neurologists in Pediatric Epilepsy Patients: Follow Up on a Quality Improvement Project Kristina Julich, USA
0215 - 0230 PM FP38 Clinical, EEG and imaging characteristics of children with Sturge-Weber syndrome: A prospective, longitudinal study Csaba Juhasz, USA
0230 - 0245 PM FP39 High prevalence of autoantibodies to N-methyl-D-aspartate receptor and the efficacy of glucocorticoids in PCDH19-related female-limited epilepsy Norimichi Higurashi, Japan
0245 - 0300 PM FP40 Early epileptic encephalopathy with suppression-burst revealing RFT1-CDG Alec Aeby, Belgium
0300 - 0315 PM FP41 Clinical markers of Postictal Generalized EEG Suppression (PGES) in children Elizabeth Kouzmitcheva, Canada
0315 - 0330 PM FP42 Who are the super responders to the ketogenic diet? Janak Nathan, India
0330 - 0345 PM FP43 Successful use of Fenfluramine as add-on treatment in Dravet syndrome: A three years prospective follow-up Berten Ceulemans, Belgium
0345 - 0400 PM FP44 Usefulness of video-eeg monitoring in children Marina Aberastury, Argentina
0400- 0415 PM FP45 Trajectories of Health and Well-being in Children with Epilepsy: Hypotheses and Methodology of a Canadian Longitudinal Study Gabriel Ronen, Canada
0415 - 0430 PM FP46 Using Self-Regulation concepts to predict sleep problems in adolescents with epilepsy Antigone Papavasiliou, Greece
0430 - 0445 PM FP47 Clinico etiological profile of infantile onset epilepsy at a tertiary care center in India Ramesh Konanki, India
0445- 0500 PM FP48 The association of febrile seizure and single nucleotide polymorphism of cyclooxygenase-2 Kun-long Hung, Taiwan
0500-0515 PM FP49  Infantile spasms: Ictal video-EEG classification based on the Delphi West Group proposal  Marina Aberastury, Argentina
0515-0530 PM FP50 Correlation between social competence and neurocognitive performance in children with epilepsy Anneli Kolk, Estonia
Chair: TBA
0200 - 0215 PM FP25 Movement Disorders in the Neuronal Ceroid Lipofusinoses Jonathan Mink, USA
0215 - 0230 PM FP26 Coprophenomena are Associated with High Clinical Impact in Tourette Syndrome Jonathan Mink, USA
0230 - 0245 PM FP27 Pediatric Dystonia: DBS and Diversity in Diencephalic Dysfunction Aaron Cardon, USA
0245 - 0300 PM FP28 Methodology of approaches to childhood hereditary ataxias Elif Acar Arslan, Turkey
0300 - 0315 PM FP29 PLA2G6 gene mutations cause evolving spinocerebellar ataxia influenced by the genotype Mustafa Salih, Saudi Arabia
0315 - 0330 PM FP30 Developmental stages of Basal Ganglia reflects Movement Disorders in Childhood Masaya Segawa, Japan
0330 - 0345 PM FP31 Phenotypical and Molecular Characterization of Patients with Neurodegeneration with Brain Iron Accumulation (NBIA) due to PKAN2 gene mutations Felippe Borlot, Canada
0345 - 0400 PM FP32 An open label clinical pilot study of resveratrol as a treatment for Friedreich ataxia Eppie Yiu, Australia
0400- 0415 PM FP33 Movement disorder phenomenology helps differentiate NMDAR encephalitis from autoimmune basal ganglia encephalitis Shekeeb Mohammad, Australia
0415 - 0430 PM FP34 Favorable response to acetazolamide in a case of glut-1 deficiency Paulina Carullo, Argentina
0430 - 0445 PM FP35 ATP1A3 Mutations and Genotype-Phenotype Correlation of Alternating Hemiplegia of Childhood in Chinese Patients Yuehua Zhang, China
0445- 0500 PM FP36 Treatment of Tremor in Cerebral Palsy with Deep Brain Stimulation Aimee Morris, USA

4th European Stroke Organisation Conference (ESOC 2018)